NCT03757481View on ClinicalTrials.gov

Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE

NACompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

March 3, 2020

Study Completion Date

March 3, 2020

Conditions
Post Thrombotic SyndromeDeep Vein ThrombosisChronic Thromboembolic Pulmonary Hypertension
Interventions
OTHER

no intervention

SF-36 questionnaire , PembQoL, Villalta score ,PembQoL

Trial Locations (11)

Unknown

Amiens University Hospital, Amiens

Angers University Hospital, Angers

Brest University Hospital, Brest

Clermont-Ferrand University Hospital, Clermont-Ferrand

Dijon University Hospital, Dijon

Grenoble University Hospital, Grenoble

Le Mans Hospital, Le Mans

Montpellier University Hospital, Montpellier

Nice University Hospital, Nice

APHP Hôpital Européen Georges Pompidou, Paris

Strasbourg University Hospital, Strasbourg

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT03757481 - Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE | Biotech Hunter | Biotech Hunter